Sign in

CIK 0001728328 · <br>Emerging growth company

InMed Pharmaceuticals Inc.

Sign in to watch
Tickers
INM MTRI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(604) 669-7207
Business address
C/O NORTON ROSE FULBRIGHT CANADA LLP, SUITE 1800 - 510 WEST GEORGIA STREET, VANCOUVER, British Columbia, Canada, V6B 0M3

Securities

  • INM Common stock Nasdaq
  • MTRI Common Stock Nasdaq
  1. 8-K Event Regulation FD disclosure
  2. 424B3 Offering Prospectus
  3. EFFECT Other Notice of Effectiveness
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. UPLOAD Other SEC-generated Letter
  6. S-1 Offering Registration Statement
  7. EFFECT Other Notice of Effectiveness
  8. EFFECT Other Notice of Effectiveness
  9. EFFECT Other Notice of Effectiveness
  10. EFFECT Other Notice of Effectiveness
  11. EFFECT Other Notice of Effectiveness
  12. 8-K Event Other events
  13. 10-K/A Report 10-K/A
  14. 8-K Event Regulation FD disclosure
  15. 10-K Report Annual Report
  16. 8-K Event Regulation FD disclosure
  17. S-8 POS Other Post-effective Amendment
  18. S-8 POS Other Post-effective Amendment
  19. POS AM Other Post-effective Amendment for Registration Statement
  20. POS AM Other Post-effective Amendment for Registration Statement

Page 16 of 27 · 533 filings